Retinoids and Substances of Abuse in HIV-1 Infection
HIV-1 感染中的类视黄醇和滥用物质
基本信息
- 批准号:6496203
- 负责人:
- 金额:$ 33.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-15 至 2007-04-30
- 项目状态:已结题
- 来源:
- 关键词:HIV infections cell line clinical research cocaine cytokine human immunodeficiency virus 1 human subject immunomodulators leukocyte activation /transformation monocyte morphine neuropathology nuclear factor kappa beta opiate alkaloid opioid receptor patient oriented research phagocytes posttranslational modifications receptor expression retinoids substance abuse related disorder tumor necrosis factor alpha virus replication vitamin receptor
项目摘要
DESCRIPTION: (provided by applicant) Neurologic disease in HIV infection has
been associated with damage to nervous system tissue induced by
pro-inflammatory cytokines and other soluble factors that are released by
activated mononuclear phagocytes (MP). In this proposal, we will examine
mechanisms by which retinoids suppress pro-inflammatory activity in immune
cells from individuals with HIV infection and in immune cell lines. Retinoids,
which are vitamin A-related compounds, have been demonstrated to suppress such
immune activity, and, in studies of m -1 infection, can suppress replication of
virus in infected mononuclear cell lines. Among individuals with HIV-1 (HIV)
infection, vitamin A deficiency has been associated with an increased risk of
developing HIV-related complications. However, in most cases, the
administration of vitamin A in clinical trials has not been associated with
improvement in HIV-related clinical parameters. Our prior studies demonstrate
that 1) parameters of vitamin A metabolism in plasma are lower among
HIV-infected individuals than among non-infected subjects and suggest that such
abnormalities can be observed in CSF; 2) plasma retinol levels are lower in
seronegative patients with chronic inflammatory neurologic disease than in
control subjects with non-inflammatory neurologic disease and treatment of
these individuals with an immunomodulatory agent is associated with specific
effects on retinoid receptor subtype expression patterns; 3) retinoid compounds
suppress pro-inflammatory cytokine production by peripheral blood immune cells
and cell lines and that, in the cell lines, retinoid-induced suppressive
activity can be inhibited by simultaneous exposure of the cells to morphine or
cocaine. Therefore, we propose the following aims for this proposal: 1) to
examine the expression of pro-inflammatory cytokine (TNF-a) by mononuclear
cells from opiate users and non-drug users with or without a history of HIV
infection; 2) to examine the effects of specific retinoid receptor activation
on the immune effects elicited in retinoid-exposed mononuclear cell lines; 3)
to examine the effects of substances of abuse (morphine and cocaine) on
specific immune responses induced by retinoid receptor agonists and receptor
antagonists in mononuclear cell lines; and 4) and to assess the role of
inhibition of nuclear NF-KB binding in the effects of retinoids and substances
of abuse on pro-inflammatory cytokine production by the patient cells and by
the mononuclear cell lines. These studies will broaden our understanding of the
immune effects of retinoid compounds in individuals with HIV infection, and may
lead to effective approaches to the treatment of the infection and its
complications with vitamin A.
描述:(由申请人提供)HIV感染的神经系统疾病
与神经系统组织损伤有关,
促炎细胞因子和其他可溶性因子,
活化的单核吞噬细胞(MP)。在本建议中,我们将研究
类维生素A抑制免疫系统中促炎活性的机制
来自HIV感染个体的细胞和免疫细胞系。类维生素A,
维生素A相关化合物,已被证明可以抑制这种
免疫活性,并且在m-1感染的研究中,可以抑制
病毒感染的单核细胞系。在艾滋病毒1型(艾滋病毒)感染者中
感染,维生素A缺乏与增加的风险有关,
出现艾滋病相关并发症然而,在大多数情况下,
在临床试验中给予维生素A与
改善艾滋病毒相关临床参数。我们之前的研究表明
1)血浆中维生素A代谢的参数低于
艾滋病毒感染者比非感染者,这表明,
在CSF中可以观察到异常; 2)血浆视黄醇水平较低,
血清阴性的慢性炎症性神经系统疾病患者比
患有非炎性神经系统疾病的对照受试者和
这些具有免疫调节剂的个体与特异性
对类维生素A受体亚型表达模式的影响; 3)类维生素A化合物
抑制外周血免疫细胞产生促炎细胞因子
在细胞系中,类维生素A诱导的抑制性
活性可通过同时将细胞暴露于吗啡或
可卡因因此,我们提出这项建议的目的如下:1)
检测单核细胞表达促炎细胞因子(TNF-α)
来自阿片类药物使用者和有或没有HIV史的非药物使用者的细胞
感染; 2)检查特异性类维生素A受体激活的影响
在类维生素A暴露的单核细胞系中引起的免疫效应; 3)
研究滥用物质(吗啡和可卡因)对
由类视色素受体激动剂和受体诱导的特异性免疫应答
单核细胞系中的拮抗剂;和4)并评估
在类维生素A和物质的作用中抑制核NF-κ B结合
滥用促炎细胞因子产生的患者细胞,
单核细胞系。这些研究将扩大我们对
类维生素A化合物对HIV感染者的免疫作用,
导致有效的方法来治疗感染及其
维生素A的并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WALTER ROYAL其他文献
WALTER ROYAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WALTER ROYAL', 18)}}的其他基金
Nicotinic Acid Receptor Activation and Brain Proinflammatory Responses in HIV-1 Transgenic Rat
HIV-1 转基因大鼠烟酸受体激活和脑促炎反应
- 批准号:
10160861 - 财政年份:2018
- 资助金额:
$ 33.19万 - 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
- 批准号:
9897455 - 财政年份:2017
- 资助金额:
$ 33.19万 - 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
- 批准号:
10083681 - 财政年份:2017
- 资助金额:
$ 33.19万 - 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
- 批准号:
10341091 - 财政年份:2017
- 资助金额:
$ 33.19万 - 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
- 批准号:
9242303 - 财政年份:2017
- 资助金额:
$ 33.19万 - 项目类别:
Studies of Cigarette Smoke Exposure in an Animal Model of HIV-1 Infection
HIV-1 感染动物模型中香烟烟雾暴露的研究
- 批准号:
8624954 - 财政年份:2013
- 资助金额:
$ 33.19万 - 项目类别:
Studies of Cigarette Smoke Exposure in an Animal Model of HIV-1 Infection
HIV-1 感染动物模型中香烟烟雾暴露的研究
- 批准号:
8735918 - 财政年份:2013
- 资助金额:
$ 33.19万 - 项目类别:
Physical Telerahabilitation in Veterans with Multiple Sclerosis
患有多发性硬化症的退伍军人的身体远程康复
- 批准号:
8838115 - 财政年份:2012
- 资助金额:
$ 33.19万 - 项目类别:
Physical Telerahabilitation in Veterans with Multiple Sclerosis
患有多发性硬化症的退伍军人的身体远程康复
- 批准号:
8499086 - 财政年份:2012
- 资助金额:
$ 33.19万 - 项目类别:
Physical Telerahabilitation in Veterans with Multiple Sclerosis
患有多发性硬化症的退伍军人的身体远程康复
- 批准号:
8277575 - 财政年份:2012
- 资助金额:
$ 33.19万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 33.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 33.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 33.19万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 33.19万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 33.19万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 33.19万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 33.19万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 33.19万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 33.19万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 33.19万 - 项目类别:
Studentship